Tender offers by Sanofi to acquire Ablynx

Tender offer by Sanofi to acquire Ablynx

Sanofi’s offer to acquire Ablynx, a biopharmaceutical company engaged in the discovery and development of Nanobodies®

Belgian Offer Documents

Prospectus and Response Memorandum

Summary of the Prospectus

Acceptance and Withdrawal Forms


U.S. Offer Documents

Press releases

IR conference call

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies